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Demethylehiortetracycline (Declomycin®) is
a relatively new tetracycline derivative closely
related chemically to chlortetracycline (Aureo-
mycin®). Demethylchlortetracycline, hereafter
referred to as DMCT, differs from chlortetra-
cycline only in the 6 position where a hydrogen
molecule has been substituted for the methyl
group found in chlortetracycline. Since its intro-
duction in 1958, several cases of DMCT photo-
sensitivity have been reported. Orentreich, et al.
(1) noted a relatively high incidence of photo-
sensitivity in a group of patients receiving DMCT
for acne vulgaris. Additional cases of photo-
sensitivity have been reported by Falk (2),
Morris (3), Fuhrman (4), and Trafton (5). Tn
the majority of these cases the photosensitivity
manifested itself as an exaggerated sunburn-like
reaction. In several cases the period of time
during which the patients had ingested the drug
was short enough to eliminate the possibility of a
photo-allergic mechanism (5, 6).
The present investigations were undertaken
in order to study photosensitivity to DMCT
under controlled conditions in a group of healthy
volunteers.
MATEHJAL5 AND METHODS
Photosensitivity Following Ingestion of DMCT
A. Natural Sunlight Studies: Thirty volunteers
received one of three types of identically appear-
ing coded capsules. Ten received 150 mg capsules
of DMCT; ten received 250 mg capsules of tetra-
cycline; and ten received 350 mg capsules of
lactose. All participants were instructed to take
one capsule four times daily and to avoid sun
exposure. The period of time the volunteers re-
ceived the capsules before deliberate sun exposure
varied from 5 to 14 days depending upon avail-
able sunlight.
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The lumbar area of the volunteers was parti-
tioned into quadrants which were exposed to
10, 20, 30 or 60 minutes of solar radiation for
one hour starting at noon. The intensity of solar
ultraviolet radiation lower than 3200 A ranged
from 300 to 400 mierowatts/em2.
Erythema readings were obtained immediately
after sun exposure, at 24, 72 and 96 hours and
weekly until all erythema had disappeared and
only hyperpigmentation remained. Erythema
responses j were assessed for the following fea-
tures: 1) intensity of erythema response to a
known erythemagenie dose of sunlight or carbon
are lamp radiation; 2) erythema threshold; and
3) persistence of erythema following exposure. All
the studies were conducted using a double-blind
test procedure.
Results: The erythema responses of the thirty
volunteers are listed in Table 1. The number of
volunteers receiving DMCT, tetracycline or lac-
tose is too small to permit calculations of statisti-
cal significance regarding the incidence of photo-
sensitivity. However, certain trends were noted:
1) Intensity of erythema responses: the erythema
responses of the DMCT volunteers appeared to
be of somewhat greater intensity than those of
the group receiving lactose or tetracycline (Tables
1 & 1A).
2) Erythema threshold: in only three of the 30
volunteers was erythema observed at sites which
had received less than 30 minutes sun exposure
when readings were made one day later. Two of
these individuals had ingested DMCT, the third
lactose. A shortened reaction time manifested by
erythema appearing during the period of actual
sun exposure was noted in four of the test group,
and all four of these individuals had received
DMCT.
3) Persistence of erythema: erythema persisted
for more than two weeks in only two individuals;
both of these had been given DMCT.
None of the volunteers who received DMCT
t Key for all erythema readings: 0—No ery-
thema; +0.5—Questionable erytbema; +1—Minimal but definite erythema; +2—Moderate
erythema; +3—Considerable erythema; +4—
Maximal erythema.
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TABLE 1
Demethyichiortetracycline ingestion sunlight studies
Gropand Volunteer Medication
Erythema Readings at 24 Hours Fol-
lowing Sun Exposure of Minutes
Complexion
10 20 30 60
I
May 4 A
B
C
D
Lactose
Lactose
DMCT
Tetracycline
7
7
7
7
0
0
0
0
1
0
0
0
0.5
0
0.5
1
3
3
2
3
Medium
Medium
Dark
Light
II
May 17 E
F
G
H
I
J
Lactose
Lactose
DMCT
DMCT
Tetracycline
Tetracycline
14
14
14
14
14
14
0
0
0.5
0
0
0
0
0
2
1
0
0.5
1
0.5
3
3
0.5
0.5
2
1
4*
4*
2
1
Dark
Medium
Light
Light
Medium
Medium
III
VEay 19 K
L
M
N
0
P
Lactose
Lactose
DMCT
DMCT
Tetracycline
Tetracycline
10
10
10
10
10
10
0
0
0
0
0
0
0
0
0
0.5
0
0
1
1
1
0.5
1
1
3
3
3
2
3
3
Light
Medium
Light
Medium
Medium
Light
Iv
May 20 Q
R
S
Lactose
DMCT
Tetracycline
7
7
7
0
0
0
0
0
0
0.5
1
1
2
2
3
Light
Medium
Medium
V
May 26 T
U
V
W
X
Y
Lactose
DMCT
DMCT
Tetracycline
Tetracycline
Tetracycline
9
9
9
9
9
9
0
0.5
0
0
0
0
0.5
0.5
0.5
0
0.5
0
1
1
1.5
0.5
1
1
2
3*
2.5*
1
2
1.5
Dark
Dark
Dark
Medium
Light
Dark
VI
May 31 Z
AA
BB
CC
DD
Lactose
Lactose
DMCT
DMCT
Tetracycline
5
5
5
5
5
0
0
0
0
0
0
0
0
0
0
1
1
0
0.5
0.5
2
2.5
3
3
1
Dark
Dark
Dark
Dark
Dark
* Erythema appeared during sun exposure.
were aware of any subjective sensations following
sun exposure. However, volunteer "S" who had
received tetracycline described a "tingling" sensa-
tion while the sites were exposed to sunlight;
examination of the sites revealed nothing note-
worthy. None of the erythematous reactions seen
were accompanied by edema.
B. Carbon Arc Lamp Studies: Twenty addi-
tional volunteers were subjected to studies with
Carbon arc radiation as the light source. Ten
volunteers received DMCT, five received tetra-
cycline and five lactose capsules. The advantage
of using Carbon arc lamp radiation was that the
same measured amount of radiation could be
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TABLE 1A
Summation of erythema intensities (from Table 1)
of individuals ingesting capsules of each group
Expressed as average total erythema/type
capsule in each group
Group
Demethyl-
chiortetra-
cycline
Tetracycline Lactose
I 2.5 4.0 3.75
II 8.75 2.25 2.25
III 3.5 4.0 4.0
IV 3.0 4.0 2.5
V 4.75 2.5 3.5
VI 3.25 1.5 3.25
Total 25.75 19.25 19.25
Average 4.3 3.2 3.2
administered both before and after the capsules
were ingested. Therefore, the erythema threshold,
the intensity of response per unit exposure, and
the persistence of erythema could be compared in
the same individual, thus eliminating the errors
inherent in comparing the erythema responses of
different individuals. The procedures used were
identical with the sunlight tests except that each
volunteer was first tested for ultraviolet sensi-
tivity by exposing 6 sites measuring 2.5 cm2
each on one side of the lumbar area, to 350 to 400
microwatts/cm2 of ultraviolet radiation (large
Sunshine Carbons*) at a target skin distance of
50 cm for 5, 10, 15, 20, 40 and 60 minutes re-
spectively. A Corex D filtert interposed between
the subject and the light source eliminated ultra-
violet radiation shorter than 2750 A. The volun-
teers then ingested the coded capsules 4 times
daily for 3 weeks at which time Carbon arc lamp
tests were repeated on the contralateral portion
of the lumbar area.
Results: Nineteen of the twenty volunteers
did not demonstrate significant differences be-
tween their pre- and post-therapy erythema
responses. Differences were observed, however,
in one volunteer who had received DMCT
(Table 2). Her minimal erythema response was
lowered from 15 minutes to 10 minutes exposure.
The intensity of her erythema response was
increased in four sites during the first week follow-
ing exposure to Carbon rc radiation. Further-
more, the persistence of her erythema which
had been less than two weeks was increased to at
* Union Carbide Co., Philadelphia, Penna.
f Corning Glass Works, Corning, N. Y.
least one month and possibly six weeks after the
ingestion of DMCT.
Photoprotection Following Topical Application
of DMCT
A. Natural Sunlight: Thirty volunteers had
23%DMCT ointment and the ointment vehicle
inuncted on symmetrical sites of their backs.
In ten volunteers the ointments were applied a
few moments prior to sun exposure, and in 20
others they were applied and covered by a dress-
ing for 24 or 72 hours prior to sun exposure. The
sites were then exposed to sunlight for one hour
starting at noon.
Results: Table 3 indicated that in 19 of 21 com
parisons where a difference in erythema existed
between the two sites, the vehicle site showed
more erythema than the DMCT ointment site.
This was interpreted as being due to a photo-
protective effect of DMCT ointment.
B. Carbon Arc Radiation: In 18 additional
volunteers (Table 4) the stratum corneum was
removed by mechanical stripping in two sym-
metrically situated sites, each 2 cm2. Subse-
quently 2 % DMCT ointment and the ointment
vehicle were applied to these sites and were
covered with dressings. Twenty-four hours later
they were exposed to known amounts of Carbon
arc radiation.
Minimal or questionable erythema resulting
from the stripping procedure was observed in
all the test sites before ultraviolet radiation was
administered. However, following irradiation a
significant difference in the intensity of erythema
was noted in 30 of the 46 pairs of test sites. In 22
comparisons, the DMCT ointment sites had less
erythema than the control vehicle site. In 8
others the converse was true.
Quantitative Evaluation of DMCT Erythema
Protection
A. Natural Sunlight: The photoprotective effect
of DMCT was studied in one volunteers by ir-
radiating skin sites through quartz cups contain-
ing DMCT solution as follows (Table 5):
Six cylindrical quartz cups, 2.9 cm in di-
ameter, containing 3 ml of 210 M, 1 .102 M,
2 10 M and 1 .10 M solutions (distilled water
This investigation was undertaken only on
one volunteer because of the extremely difficult
conditions of immobilizing an individual for one
hour with quarts cups suspended over the back.§ The quartz cups had but minimal ultraviolet
absorbing properties per se or when filled with 7
mm of a 1% lactose solution.
TABLE 3
2% demethylchlortetracyeline and control oint-
meats comparative erythema readings at 24 hours
after exposure to 1 hour of sunlight
Thirty volunteers
Number of
Volunteers
Time Ointment in
Contact with Skin
Surface Before Sun
Exposure (hours)
Eryth
C > D
ma Response
C < D C = D
10 0 6 1 3
11 24 7 1 3
9 72 6 0 3
Totals 19 2 9
Key: D—DMCT ointment; C—Control oint
ment.
TABLE 4
2% demethylchlortetracycline and control oint-
ments comparative erythema readings of stripped
skin 24 hours after exposure to carbon arc
radiation
Eighteen volunteers
No. of
Volunteers
C-Arc Exposure
(minutes)
Erythema Response
C>D C<D C=D
10 0 3 0 7
4 5 3 0 1
11 10 6 1 4
3 20 2 1 0
11 30 4 5 2
7 60 4 1 2
Total 22 8 16
Key: D—DMCT ointment; C—Contro] oint-
ment.
acidified to pH 2—3 with HC1) of DMCT were
suspended 1.0 to 2.0 mm above the skin surface
of the back of the volunteer.
B. Mercury Vapor Lamp Radiation: This study
was performed in a manner identical to that of
the previous one except that a Hanovia Hot
Quartz Mercury Lamp was used as a light source.
Each volunteer received a dose of radiation
expected to produce a 1.5—2.0 erythema response
(7 50—850 microwatts/cm2) through DMCT
solutions in the 6 quartz cups to the lumbar area.
Erythema readings were obtained at 6 and 24
hours respectively following radiation.
RESULTS
The erythema responses following natural sun-
light and mercury vapor lamp radiation are
listed in Table 5. No erythema was observed at
skin sites protected with 2 . 10 M, 1 .10 M or
2• 10 M DMCT solutions; however, when the
concentration of DMCT was reduced to 1 .10
moles per liter, there was only slightly less
erythema than at the control sites.
DISCUSSION
The photosensitivity produced by DMCT ob-
served in our volunteers manifested itself as an
exaggerated sunburn-like reaction. It was char-
acterized by a shortened reaction time, a lowering
of the erythema threshold, an increase in the
intensity of response and prolonged persistence
of post-irradiation erythema. Studies to be
reported elsewhere (1) show that DMCT photo-
sensitivity usually disappears soon after discon-
tillUation of the drug and could not be elicited
through a 3 mm pane of window glass. Additional
data (6) indicates that photosensitivity may
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TABLE 2
Lumbar area erythema readings at various time intervals before and after demethylchlortetracycline ingestion
24 Hours 1 Week 2 Weeks
Time of Carbon
Arc Exposure
5 minutes
10 minutes
15 minutes
20 minutes
40 minutes
60 minutes
3 Weeks 4 Weeks
Pre
0
0
1
2
3
4
Post
0
1*
2*
2
3
4
5 Weeks
Pre
0
0
0
0
1
2
Pre
0
0
0
0
0
Post
0
0
0
0
2*
3*
S Weeks
Post
0
0
0
0
0.5
1*
Pre
0
0
0
0
0
0
Post
0
0
0
0
0.5
1*
Pre
0
0
0
0
0
0
Post
0
0
0
0
0
1*
Pre
0
0
0
0
0
0
Post
0
0
0
0
0
0.5
Pre
0
0
0
0
0
0
Key: Pre—before DMCT ingestion; Post-—after DMCT ingestion.
* Abnormal finding.
Post
0
0
0
0
0
0.5
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TABLE S
iSunscreeninq effect of deinethylchlortetracycline solution in quartz cups
Volunteer Radistioo Source Estimated Ery-
Erythema Readings Using Various Cooreotratloos of Dc-
methylchlortetracyrlioe Solutions (7 mm. depth)
Cootcol
2.10—' M 1.l0—'M 2.I0 11 l.l0 M
EOH 11011
A
B
C
D
E
Mercury vapor lamp
Mercury vapor lamp
Mercury vapor lamp
Mercury vapor lamp
Mercuryvaporlamp
1.5—2
1.5—2
1.5—2
1.5—2
1.5—2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.5
1.0
1.5
0.5
0.5
2
1.5
2
2
1
2
2
1.5
1
1
AA Natural sunlight 2—3 0 0 0 1 2 2
occur less than five days after DMCT is ingested.
Because of the morphology, short incubation
period, and action spectrum, the responses ob-
served by us can be classified as phototoxie rather
than photoallergic.
It is difficult to estimate the probable incidence
of photosensitivity in a large population group on
the basis of the small number of volunteers in
this study. The incidence would obviously depend
on the dose of DMCT ingested, the blood and
skin levels resulting therefrom, the intensity of
exposure to sunlight, as well as on other factors.
Under actual conditions of use the incidence of
DMCT photosensitivity dermatitis appears to be
exceedingly low. From the practical viewpoint
it is important that because of the spectral range
involved, a phototoxie reaction is prevented by
ordinary window glass. This observation was
demonstrated by Kligman (6) and confirmed in
studies by Orentreieh, }Tarber and Tromoviteh (1).
The studies with topically applied DMCT oint-
ment demonstrate a photoproteetive action of
topically applied DMCT. Under the conditions
of our study, with DMCT solutions in quartz
cups, DMCT was found to have excellent sun-
screening properties at a concentration of 2 .10
M/l. Photo-electric absorption spectral studies
(7) correlate well with the clinical observation
that DMCT absorbs energy in the erythema pro-
ducing portion of the solar radiation reaching this
area in the summer months. This sunsereening
action is not as good as that of para-amino
benzoie acid or tannie acid (8), but compares well
with other commonly used photoproteetive agents
such as phenyl salicylate and glyeeryl para-
aminobenzoate.
SUMMARY
1. Photosensitivity engendered by ingested
demethylehlortetracyeline manifested itself as
an exaggerated sunburn-type reaction in the form
of a decreased erythema threshold and greater
persistence and intensity of erythema.
2. The available evidence suggests that the
reactions seen in these tests were based on a
phototoxie rather than a photo-allergic
mechanism.
3. A sunsereening effect in the ultraviolet range
of the light spectrum was noted after topical ap-
plication of DMCT.
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